{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:47:21Z","timestamp":1782265641686,"version":"3.54.5"},"reference-count":45,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2026,6,21]],"date-time":"2026-06-21T00:00:00Z","timestamp":1782000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCM"],"abstract":"<jats:p>Cardiovascular disease remains the leading cause of mortality in kidney transplant recipients (KTRs). Arterial hypertension is present in a vast majority of patients after kidney transplantation, constituting the most prevalent cardiovascular comorbidity, and is a significant modifiable risk factor for other cardiovascular complications and graft loss. The 2024 Kidney Disease: Improving Global Outcomes (KDIGO) guidelines do not address blood pressure control strategies in KTRs, and the prior 2021 KDIGO recommendations targeting values below 130\/80 mmHg rely primarily on data extrapolated from non-KTR populations. This represents an existing evidence gap in the management of post-transplant hypertension. Dihydropyridine calcium channel blockers and angiotensin receptor blockers remain first-line antihypertensive medications, although most studies assessing their effectiveness in KTRs date back more than 15 years. The current treatment guidelines are based largely on limited and outdated data. Optimal selection and individualization of immunosuppressive therapy and\u2014when feasible\u2014its modification in some KTRs may be important in improving blood pressure control. This includes, for example, a reduction in the calcineurin inhibitor or steroid dose, as well as the use of mTOR inhibitors or belatacept. The lack of large, up-to-date randomized trials in the KTR population underscores the pressing need for further extensive research focused on this patient group.<\/jats:p>","DOI":"10.3390\/jcm15124808","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:03:23Z","timestamp":1782263003000},"page":"4808","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Post-Transplant Hypertension in Kidney Recipients: Current Knowledge, Gaps and Future Directions"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-1473-5960","authenticated-orcid":false,"given":"Alicja","family":"Danieluk","sequence":"first","affiliation":[{"name":"Department of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-6825-255X","authenticated-orcid":false,"given":"Tomasz","family":"Pilecki","sequence":"additional","affiliation":[{"name":"Department of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2563-0549","authenticated-orcid":false,"given":"Bartosz","family":"Rutka","sequence":"additional","affiliation":[{"name":"Department of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6613-7638","authenticated-orcid":false,"given":"Krzysztof","family":"Mucha","sequence":"additional","affiliation":[{"name":"Department of Transplantology, Immunology, Nephrology and Internal Diseases, Medical University of Warsaw, 02-006 Warsaw, Poland"},{"name":"Institute of Biochemistry and Biophysics, Polish Academy of Sciences, 02-106 Warsaw, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,6,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5500\/wjt.v12.i8.211","article-title":"Hypertension in Kidney Transplant Recipients","volume":"12","author":"Alexandrou","year":"2022","journal-title":"World J. Transplant."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1093\/ndt\/gfz053","article-title":"Cardiovascular Disease in the Kidney Transplant Recipient: Epidemiology, Diagnosis and Management Strategies","volume":"34","author":"Rangaswami","year":"2019","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1111\/j.1600-6143.2005.01093.x","article-title":"Improved Long-Term Outcomes After Renal Transplantation Associated with Blood Pressure Control","volume":"5","author":"Opelz","year":"2005","journal-title":"Am. J. Transplant."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Tantisattamo, E., Molnar, M.Z., Ho, B.T., Reddy, U.G., Dafoe, D.C., Ichii, H., Ferrey, A.J., Hanna, R.M., Kalantar-Zadeh, K., and Amin, A. (2020). Approach and Management of Hypertension After Kidney Transplantation. Front. Med., 7.","DOI":"10.3389\/fmed.2020.00229"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"e939472-1","DOI":"10.12659\/AOT.939472","article-title":"Impact of Blood Pressure on Risk of Graft Failure or Death Among Patients After Kidney Transplantation in a 10-Year Observational Period: A Single-Center Retrospective Analysis","volume":"28","author":"Pilecki","year":"2023","journal-title":"Ann. Transplant."},{"key":"ref_6","first-page":"CD003598.pub3","article-title":"Antihypertensive Treatment for Kidney Transplant Recipients","volume":"2024","author":"Natale","year":"2024","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","article-title":"KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.kint.2020.10.026","article-title":"Executive Summary of the KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease","volume":"99","author":"Cheung","year":"2021","journal-title":"Kidney Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1681\/ASN.2014080834","article-title":"Assessment and Management of Hypertension in Transplant Patients","volume":"26","author":"Weir","year":"2015","journal-title":"J. Am. Soc. Nephrol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Gelpi, R., Casas, A., Taco, O., Sanchez-Baya, M., Nassiri, M., Bolufer, M., Paul, J., Molina, M., Ca\u00f1as, L., and Vila, A. (2025). Kidney Transplant: More than Immunological Problems. J. Clin. Med., 14.","DOI":"10.3390\/jcm14062101"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/ckj\/sfab135","article-title":"Assessment of Hypertension in Kidney Transplantation by Ambulatory Blood Pressure Monitoring: A Systematic Review and Meta-Analysis","volume":"15","author":"Pisano","year":"2022","journal-title":"Clin. Kidney J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"SPRINT Research Group (2015). A Randomized Trial of Intensive versus Standard Blood-Pressure Control. N. Engl. J. Med., 373, 2103\u20132116.","DOI":"10.1056\/NEJMoa1511939"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1016\/j.ekir.2024.12.004","article-title":"Blood Pressure Goals and Outcomes in Kidney Transplant Recipients in an Analysis of the Collaborative Transplant Study","volume":"10","author":"Speer","year":"2025","journal-title":"Kidney Int. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejim.2024.05.033","article-title":"2024 European Society of Hypertension Clinical Practice Guidelines for the Management of Arterial Hypertension","volume":"126","author":"Kreutz","year":"2024","journal-title":"Eur. J. Intern. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1093\/eurheartj\/ehae178","article-title":"2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension","volume":"45","author":"McEvoy","year":"2024","journal-title":"Eur. Heart J."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e212","DOI":"10.1161\/HYP.0000000000000257","article-title":"2025 AHA\/ACC\/AANP\/AAPA\/ABC\/ACCP\/ACPM\/AGS\/AMA\/ASPC\/NMA\/PCNA\/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"82","author":"Jones","year":"2025","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1097\/TP.0000000000001774","article-title":"Toward Establishing Core Outcome Domains For Trials in Kidney Transplantation: Report of the Standardized Outcomes in Nephrology\u2014Kidney Transplantation Consensus Workshops","volume":"101","author":"Tong","year":"2017","journal-title":"Transplantation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1097\/TP.0000000000002125","article-title":"Establishing a Core Outcome Measure for Graft Health: A Standardized Outcomes in Nephrology-Kidney Transplantation (SONG-Tx) Consensus Workshop Report","volume":"102","author":"Tong","year":"2018","journal-title":"Transplantation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","article-title":"Antihypertensive Drugs","volume":"124","author":"Laurent","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1111\/j.1751-7176.2011.00513.x","article-title":"Calcium Channel Blockers: Calcium Channel Blockers","volume":"13","author":"Elliott","year":"2011","journal-title":"J. Clin. Hypertens."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5301\/jn.5000174","article-title":"Pathogenesis of Calcineurin Inhibitor\u2013Induced Hypertension","volume":"25","author":"Hoorn","year":"2012","journal-title":"J. Nephrol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/01.tp.0000220480.84449.71","article-title":"Slowing the Progression of Chronic Allograft Nephropathy by Conversion from Cyclosporine to Tacrolimus: A Randomized Controlled Trial","volume":"81","author":"Meier","year":"2006","journal-title":"Transplantation"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/TP.0b013e3182958552","article-title":"Impact of Late Calcineurin Inhibitor Withdrawal on Ambulatory Blood Pressure and Carotid Intima Media Thickness in Renal Transplant Recipients","volume":"96","author":"Mourer","year":"2013","journal-title":"Transplantation"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1399-0012.2004.00171.x","article-title":"Analysis of the Cardiovascular Risk Profile in Stable Kidney Transplant Recipients after 50% Cyclosporine Reduction","volume":"18","author":"Wong","year":"2004","journal-title":"Clin. Transplant."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1034\/j.1399-0012.2000.140608.x","article-title":"Cyclosporine Withdrawal in Stable Renal Transplant Recipients after Azathioprine-mycophenolate Mofetil Conversion","volume":"14","author":"Thervet","year":"2000","journal-title":"Clin. Transplant."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1111\/j.1600-6143.2004.00499.x","article-title":"Pilot Randomized Study of Early Tacrolimus Withdrawal from a Regimen with Sirolimus Plus Tacrolimus in Kidney Transplantation","volume":"4","author":"Grinyo","year":"2004","journal-title":"Am. J. Transplant."},{"key":"ref_28","first-page":"CD005632.pub2","article-title":"Steroid Avoidance or Withdrawal for Kidney Transplant Recipients","volume":"2009","author":"Pascual","year":"2009","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/ndt\/gfr374","article-title":"Very Early Steroid Withdrawal or Complete Avoidance for Kidney Transplant Recipients: A Systematic Review","volume":"27","author":"Pascual","year":"2012","journal-title":"Nephrol. Dial. Transplant."},{"key":"ref_30","first-page":"CD005632.pub4","article-title":"Steroid Avoidance or Withdrawal for Kidney Transplant Recipients","volume":"2026","author":"Oliveras","year":"2026","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/ctr.12565","article-title":"Cardiac Response to Early Conversion from Calcineurin Inhibitor to Everolimus in Renal Transplant Recipients\u2014A Three-yr Serial Echocardiographic Substudy of the Randomized Controlled CENTRAL Trial","volume":"29","author":"Murbraech","year":"2015","journal-title":"Clin. Transplant."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/ctr.12413","article-title":"Differential Impact of Belatacept and Cyclosporine A on Central Aortic Blood Pressure and Arterial Stiffness after Renal Transplantation","volume":"28","author":"Seibert","year":"2014","journal-title":"Clin. Transplant."},{"key":"ref_33","first-page":"CD010699.pub2","article-title":"Belatacept for Kidney Transplant Recipients","volume":"2014","author":"Masson","year":"2014","journal-title":"Cochrane Database Syst. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/ckj\/sfad007","article-title":"Sodium-Glucose Cotransporter-2 Inhibitor Therapy in Kidney Transplant Patients with Type 2 or Post-Transplant Diabetes: An Observational Multicentre Study","volume":"16","year":"2023","journal-title":"Clin. Kidney J."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.5646\/ch.2025.31.e26","article-title":"Impact of SGLT2 Inhibitors on Blood Pressure among Kidney Transplant Recipients: Insights from a French Multicentric Cohort (GREAT ASTRE)","volume":"31","author":"Maigret","year":"2025","journal-title":"Clin. Hypertens."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1097\/TP.0000000000005496","article-title":"SGLT2 Inhibitors and GLP-1 Receptor Agonists in Kidney Transplantation: A Systematic Review and Meta-Analysis","volume":"110","author":"Lee","year":"2026","journal-title":"Transplantation"},{"key":"ref_37","first-page":"885","article-title":"Use of Glucagon-like Peptide Type 1 Receptor Agonists in Kidney Transplant Recipients","volume":"44","author":"Vigara","year":"2024","journal-title":"Nefrol. Engl. Ed."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Bellos, I., Lagiou, P., Benetou, V., and Marinaki, S. (2024). Safety and Efficacy of Sodium-Glucose Transport Protein 2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Diabetic Kidney Transplant Recipients: Synthesis of Evidence. J. Clin. Med., 13.","DOI":"10.3390\/jcm13206181"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Ati\u0107, A., Matija\u0161evi\u0107 \u0160kerlj, J., Juri\u0107, I., Katalini\u0107, L., Furi\u0107 \u010cunko, V., Kljaji\u0107, M., Sablji\u0107, Z., Jelakovi\u0107, B., and Ba\u0161i\u0107-Juki\u0107, N. (2024). Factors Associated with Hyperpolypharmacy and Complex Medication Regimens in Kidney Transplant Recipients. J. Clin. Med., 13.","DOI":"10.3390\/jcm13133716"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(22)02034-7","article-title":"Dual Endothelin Antagonist Aprocitentan for Resistant Hypertension (PRECISION): A Multicentre, Blinded, Randomised, Parallel-Group, Phase 3 Trial","volume":"400","author":"Schlaich","year":"2022","journal-title":"Lancet"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1056\/NEJMoa2507109","article-title":"Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension","volume":"393","author":"Flack","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1001\/jama.2023.16029","article-title":"Aldosterone Synthase Inhibition With Lorundrostat for Uncontrolled Hypertension: The Target-HTN Randomized Clinical Trial","volume":"330","author":"Laffin","year":"2023","journal-title":"JAMA"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1001\/jama.2025.9413","article-title":"Lorundrostat in Participants With Uncontrolled Hypertension and Treatment-Resistant Hypertension: The Launch-HTN Randomized Clinical Trial","volume":"334","author":"Saxena","year":"2025","journal-title":"JAMA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1056\/NEJMoa2208391","article-title":"Zilebesiran, an RNA Interference Therapeutic Agent for Hypertension","volume":"389","author":"Desai","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1001\/jama.2025.6681","article-title":"Add-On Treatment With Zilebesiran for Inadequately Controlled Hypertension: The KARDIA-2 Randomized Clinical Trial","volume":"334","author":"Desai","year":"2025","journal-title":"JAMA"}],"container-title":["Journal of Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4808\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T01:26:41Z","timestamp":1782264401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2077-0383\/15\/12\/4808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,21]]},"references-count":45,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["jcm15124808"],"URL":"https:\/\/doi.org\/10.3390\/jcm15124808","relation":{},"ISSN":["2077-0383"],"issn-type":[{"value":"2077-0383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,21]]}}}